Highlights
- Praemium plans major technology division restructure after Technotia acquisition.
- Headcount expected to fall about 15% in Australia operations.
- PPS shares rose 14.93% to AUD 0.77 on 17 Feb.
Shares of Praemium Limited (ASX:PPS) climbed 14.93% to AUD 0.77 on 17 February after the company announced a significant organisational restructure within its technology division. The update follows the acquisition of Technotia Group Pty Ltd (Technotia Laboratories) in January 2026.
Technology Division Realignment
The Melbourne-based financial services group stated that the restructure will reshape its cost base and refine technology performance and functionality. The changes aim to remove duplicate IT development, maintenance and infrastructure roles created after integrating Technotia Laboratories.
Following integration, the company will reduce full-time equivalent (FTE) roles in Australia and close its long-running software development operations in Armenia by the end of FY26.
Praemium indicated that, despite workforce reductions, its underlying technology capabilities and automation processes are expected to improve through the incorporation of Technotia Laboratories’ scientific and development expertise.
Headcount Reduction and Cost Impact
The consultation process with affected Australian employees is underway. Once implemented, the restructure is anticipated to lower headcount by approximately 15% and reduce direct staff salaries by around AUD 9 million.
In Armenia, workforce changes will take effect in the fourth quarter of FY26, subject to required notice periods. The Armenia adjustment is expected to cut headcount by roughly 13% from the pre-restructure base and reduce direct staff salaries by about AUD 3.5 million.
After incorporating salaries linked to the Technotia Laboratories team, Praemium expects its overall annual technology salary budget, excluding incentives, to decline by around AUD 9 million on a run-rate basis compared with the level before the acquisition.
One-Off Costs and Next Update
Any cost savings in FY26 are expected to be offset by redundancy expenses estimated at approximately AUD 3.3 million.
Further details regarding the financial impact of the Technotia Laboratories acquisition, along with the restructuring effects on operating costs and capital expenditure, are scheduled to be provided at the company’s half-year results announcement on 23 February 2026.
Praemium Limited is implementing a technology-focused restructure following the acquisition of Technotia Laboratories, targeting cost reductions and integration efficiencies. The plan includes workforce reductions in Australia and the closure of Armenian operations by FY26 end, with anticipated salary savings offset by redundancy costs in the near term. Investors are monitoring the upcoming half-year results for further clarity on operating cost and capital expenditure impacts.
FAQs
Q1. Why did Praemium Limited shares rise on 17 February 2026?
PPS shares gained 14.93% to AUD 0.77 following the announcement of a technology division restructure and cost reduction plan.
Q2. How much headcount reduction is expected?
The restructure is expected to reduce Australian headcount by around 15%, with an additional ~13% reduction in Armenia from the pre-restructure base.
Q3. What is the estimated salary cost reduction?
Direct staff salaries are expected to decrease by around AUD 9 million in Australia and AUD 3.5 million in Armenia, with an overall run-rate reduction of about AUD 9 million after integration.
Disclaimer:
This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.
Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.
There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.
Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.
The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.
The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.
Kalkine does not issue, sell or deal in any financial products.
This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.
To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.
Please also read our Terms & Conditions and Financial Services Guide for further information.
Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.
Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.
Copyright 2026 Krish Capital Pty. Ltd. (ABN 61629651510). All Rights Reserved. No part of this Article, or its content, may be reproduced in any form without our prior consent.